Literature DB >> 26186675

Reactions of CF3-enones with arenes under superelectrophilic activation: a pathway to trans-1,3-diaryl-1-CF3-indanes, new cannabinoid receptor ligands.

Roman O Iakovenko1, Anna N Kazakova, Vasiliy M Muzalevskiy, Alexander Yu Ivanov, Irina A Boyarskaya, Andrea Chicca, Vanessa Petrucci, Jürg Gertsch, Mikhail Krasavin, Galina L Starova, Andrey A Zolotarev, Margarita S Avdontceva, Valentine G Nenajdenko, Aleksander V Vasilyev.   

Abstract

4-Aryl-1,1,1-trifluorobut-3-en-2-ones ArCH[double bond, length as m-dash]CHCOCF3 (CF3-enones) react with arenes in excess of Brønsted superacids (TfOH, FSO3H) to give, stereoselectively, trans-1,3-diaryl-1-trifluoromethyl indanes in 35-85% yields. The reaction intermediates, the O-protonated ArCH[double bond, length as m-dash]CHC(OH(+))CF3 and the O,C-diprotonated ArHC(+)CH2C(OH(+))CF3 species, have been studied by means of (1)H, (13)C, (19)F NMR, and DFT calculations. Both types of the cations may participate in the reaction, depending on their electrophilicity and electron-donating properties of the arenes. The formation of CF3-indanes is a result of cascade reaction of protonated CF3-enones to form chemo-, regio- and stereoselectively three new C-C bonds. The obtained trans-1,3-diaryl-1-trifluoromethyl indanes were investigated as potential ligands for cannabinoid receptors CB1 and CB2 types. The most potent compound showed sub-micromolar affinity for both receptor subtypes with a 6-fold selectivity toward the CB2 receptor with no appreciable cytotoxicity toward SHSY5Y cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26186675     DOI: 10.1039/c5ob01072a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  1 in total

1.  Cs₂CO₃-Initiated Trifluoro-Methylation of Chalcones and Ketones for Practical Synthesis of Trifluoromethylated Tertiary Silyl Ethers.

Authors:  Cheng Dong; Xing-Feng Bai; Ji-Yuan Lv; Yu-Ming Cui; Jian Cao; Zhan-Jiang Zheng; Li-Wen Xu
Journal:  Molecules       Date:  2017-05-18       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.